NASDAQ:MYGN - Myriad Genetics, Inc.
$27.52
 $-0.99
-3.47%
11:50AM EDT
2019-07-22
Myriad Genetics, Inc. is a molecular diagnostic company. The Company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. The Company operates through two segments: diagnostics and other. The diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to drug therapy and guide a patient's dosing to enable optimal treatment, or assess a patient's risk of disease progression and disease recurrence. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services, such as finance, human resources, legal and information technology. Its molecular diagnostic tests include myRisk Hereditary Cancer, BRACAnalysis CDx and COLARIS. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  MYGN     avg for
industry  
  avg for
sector  
42 stocks weight:  68. 42   217. 37   399. 45  
42 stocks rank:  2. 11 K 1. 27 K 716. 99  
# analyst opinions:  11. 00   13. 21   13. 71  
mean recommendation:  2. 80   2. 10   2. 04  

quick ratio:  2. 73   5. 49   1. 88  
current ratio:  3. 15   5. 87   2. 36  

target price low:  18. 00   83. 44   114. 90  
target price avg:  32. 91   106. 20   137. 90  
target price high:  47. 00   132. 30   158. 97  
1-yr high:  50. 34   111. 86   142. 57  
last close:  28. 51   86. 79   125. 44  
50-day avg:  25. 57   86. 68   122. 63  
200-day avg:  31. 17   89. 22   121. 38  
1-yr low:  22. 67   69. 78   100. 51  
volume:  2. 34 M 2. 62 M 3. 43 M
50-day avg volume:  1. 02 M 3. 20 M 4. 16 M
200-day avg volume:  966. 53 K 2. 99 M 4. 75 M

1-day return:  6. 86 % -1. 30 % -0. 99 %
this week return:  10. 85 % 0. 45 % -0. 20 %
12-wk return:  -10. 20 % 0. 94 % 4. 84 %
52-wk return:  -39. 03 % -1. 30 % 10. 55 %

enterprise value (EV):  2. 21 B 45. 10 B 122. 38 B
market cap:  2. 09 B 38. 96 B 108. 40 B
EBITDA:  117. 50 M 4. 20 B 8. 19 B
enterprise multiple (EV/EBITDA):  18. 77   5. 38   11. 93  
enterprise/revenue (EV/R):  2. 57   57. 92   10. 21  
total revenue:  858. 50 M 9. 91 B 39. 98 B
total debt:  263. 40 M 10. 90 B 17. 48 B
debt/equity:  24. 35   57. 18   120. 05  
net income (common):  21. 00 M 2. 07 B 4. 05 B

shares outstanding:  73. 37 M 538. 09 M 1. 24 B
shares:  61. 41 M 548. 00 M 1. 22 B
shares short:  13. 88 M 10. 98 M 11. 87 M
shares short prior month:  14. 41 M 9. 32 M 12. 05 M
short ratio:  11. 14   5. 60   3. 34  
short % of float:  25. 77 % 6. 48 % 2. 64 %
total cash/share:  2. 04   10. 98   9. 19  
total cash:  149. 70 M 5. 93 B 6. 10 B
free cash flow:  111. 85 M 2. 92 B 4. 55 B
operating cash flow:  100. 10 M 3. 80 B 5. 78 B

book value:  14. 74   13. 35   27. 45  
price/book:  1. 93   4. 60   8. 78  
gross profits:  595. 40 M 7. 44 B 36. 13 B
operating margins:  5. 57 % -308. 40 % -28. 55 %
EBITDA margins:  13. 69 % 13. 17 % 23. 38 %
profit margins:  2. 45 % 10. 44 % 14. 18 %
gross margins:  77. 15 % 35. 80 % 55. 40 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 66 % 1. 03 %

1-yr EPS:  0. 28   2. 10   4. 23  
forward EPS:  1. 86   3. 45   7. 10  
P/E:  101. 46   1. 90   32. 10  
forward P/E:  15. 33   6. 46   15. 47  
PE/G:  13. 22   0. 70   -0. 54  
growth:  7. 67 % 265. 63 % 79. 11 %
earnings high:  0. 50   0. 89   1. 68  
earnings avg:  0. 47   0. 70   1. 57  
earnings low:  0. 41   0. 46   1. 46  
revenue high:  223. 40 M 2. 57 B 11. 07 B
revenue avg:  220. 99 M 2. 51 B 10. 91 B
revenue low:  219. 78 M 2. 45 B 10. 73 B
earnings growth:  -30. 80 % 12. 05 % 30. 99 %
1-qtr earnings growth:  -24. 20 % 9. 70 % 30. 42 %
return on assets:  2. 15 % -2. 34 % 5. 28 %
return on equity:  2. 06 % -90. 08 % 133. 53 %
revenue growth:  18. 30 % 265. 25 % 73. 68 %
revenue/share:  11. 82   12. 72   60. 04  

beta (1yr vs S&P500):  0. 71   1. 27   0. 91  
sharpe (1yr):  -0. 55   0. 16   0. 77  


Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-21 : MYGN
.    138.477 =       138.477 :: --> INITIAL WEIGHT <--
.    + 0.281 =       138.758 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 0.739 =       102.504 :: P/E factor
.    x 0.827 =        84.791 :: PE/G factor
.     x 1.63 =       138.231 :: beta factor
.    x 0.837 =       115.665 :: sharpe factor
.    x 2.537 =       293.401 :: current ratio factor
.    x 1.257 =       368.765 :: quick ratio factor
.    x 1.044 =       384.961 :: short ratio factor
.    x 1.022 =       393.246 :: return on assets factor
.    x 1.021 =       401.342 :: return on equity factor
.    x 0.888 =       356.424 :: earnings growth factor
.    x 1.345 =       479.283 :: revenue growth factor
.    x 1.044 =        500.54 :: EV/R factor
.     x 1.01 =       505.358 :: price-to-book factor
.    x 1.089 =       550.199 :: EBITDA factor
.    x 1.628 =       895.703 :: EBITDA vs industry factor
.    x 3.408 =      3052.655 :: debt-to-revenue factor
.    x 1.194 =      3645.144 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.121 =      7730.596 :: sector+industry 1-year gains factor
.    x 1.009 =      7803.481 :: industry 12-weeks return factor
.    x 1.308 =     10206.084 :: industry 2-weeks return factor
.    x 0.922 =      9409.015 :: company one-year gains+dividend factor
.    x 3.487 =     32806.875 :: company 13 weeks' performance factor
.    x 1.187 =     38954.968 :: 5-day avg > 50-day avg
.    x 0.985 =     38381.941 :: "drift" penalty 5 days ago
.    / 1.954 =     19646.232 :: overall "drift" factor
.    x 0.692 =     13586.667 :: largest single-day jump factor
.        x 1 =     13586.667 :: volatility factor
.        x 1 =     13586.667 :: 42-day volatility factor
.    x 1.896 =     25758.788 :: notable returns + performance factor
.    x 2.736 =     70471.671 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 1.159 =       81692.9 :: forward EPS factor
.    x 1.659 =    135521.864 :: forward P/E factor
.    x 1.185 =    160554.446 :: industry recommendation factor
.    x 1.647 =    264421.614 :: company recommendation factor
.    x 1.003 =    265152.841 :: factor historical industry gain for week 29
.    x 0.907 =    240582.589 :: target low factor
.    x 1.131 =    272086.949 :: target mean factor
.    x 1.034 =    281289.894 :: target high factor
.    x 8.809 =   2477962.737 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        39.676 :: reduced for readability
.    + 26.89 =        66.566 :: add/subtract for investor sentiment
.    + 1.854 =         68.42 :: earnings report in 29 days
.                               --> FINAL WEIGHT <--
.                      68.42 :: FINAL WEIGHT for NASDAQ:MYGN


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org